{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:51:01Z","timestamp":1790268661290,"version":"4.1.0"},"reference-count":60,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Lublin","award":["DS 474"],"award-info":[{"award-number":["DS 474"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Malignant melanoma is a skin cancer characterized by rapid development, poor prognosis and high mortality. Due to the frequent drug resistance and\/or early metastases in melanoma, new therapeutic methods are urgently needed. The study aimed at assessing the cytotoxic and antiproliferative effects of scoparone and fraxetin in vitro, when used alone and in combination with three cytostatics: cisplatin, mitoxantrone, and docetaxel in four human melanoma cell lines. Our experiments showed that scoparone in the concentration range tested up to 200 \u00b5M had no significant effect on the viability of human malignant melanoma (therefore, it was not possible to evaluate it in combination with other cytostatics), while fraxetin inhibited cell proliferation with IC50 doses in the range of 32.42\u201373.16 \u00b5M, depending on the cell line. Isobolographic analysis allowed for the assessment of the interactions between the studied compounds. Importantly, fraxetin was not cytotoxic to normal keratinocytes (HaCaT) and melanocytes (HEMa-LP), although it slightly inhibited their viability at high concentrations. The combination of fraxetin with cisplatin and mitoxantrone showed the additive interaction, which seems to be a promising direction in melanoma therapy. Unfortunately, the combination of fraxetin with docetaxel may not be beneficial due to the antagonistic antiproliferative effect of both drugs used in the mixture.<\/jats:p>","DOI":"10.3390\/ijms24010212","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T02:09:03Z","timestamp":1671761343000},"page":"212","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Fraxetin Interacts Additively with Cisplatin and Mitoxantrone, Antagonistically with Docetaxel in Various Human Melanoma Cell Lines\u2014An Isobolographic Analysis"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7099-1968","authenticated-orcid":false,"given":"Paula","family":"Wr\u00f3blewska-\u0141uczka","sequence":"first","affiliation":[{"name":"Department of Occupational Medicine, Medical University of Lublin, ul. Jaczewskiego 8b, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Grabarska","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Medical University of Lublin, ul. Chod\u017aki 1, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7075-1051","authenticated-orcid":false,"given":"Agnieszka","family":"G\u00f3ralczyk","sequence":"additional","affiliation":[{"name":"Department of Occupational Medicine, Medical University of Lublin, ul. Jaczewskiego 8b, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Marz\u0119da","sequence":"additional","affiliation":[{"name":"Department of Occupational Medicine, Medical University of Lublin, ul. Jaczewskiego 8b, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3059-0393","authenticated-orcid":false,"given":"Jarogniew J.","family":"\u0141uszczki","sequence":"additional","affiliation":[{"name":"Department of Occupational Medicine, Medical University of Lublin, ul. Jaczewskiego 8b, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejca.2009.10.032","article-title":"Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline","volume":"46","author":"Garbe","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ctrv.2013.04.006","article-title":"Immunotherapy for advanced melanoma: Fulfilling the promise","volume":"39","author":"Gogas","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"ref_4","first-page":"653","article-title":"Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines\u2014In vitro studies","volume":"9","author":"Legut","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pdpdt.2011.08.004","article-title":"Mitoxantrone as a prospective photosensitizer for photodynamic therapy of breast cancer","volume":"9","author":"Montazerabadi","year":"2012","journal-title":"Photodiagnosis. Photodyn. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/0959-8049(92)90241-S","article-title":"Unexpected prolonged myelosuppression after mitomycin, mitoxantrone and methotrexate","volume":"28","author":"Muhonen","year":"1992","journal-title":"Eur. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pjnns.2013.12.005","article-title":"The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients","volume":"48","author":"Kochanowski","year":"2014","journal-title":"Neurol Neurochir. Pol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s11658-019-0164-y","article-title":"Progress in research on paclitaxel and tumor immunotherapy","volume":"24","author":"Zhu","year":"2019","journal-title":"Cell Mol. Biol. Lett."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.chembiol.2013.01.014","article-title":"The binding sites of microtubule-stabilizing agents","volume":"20","author":"Field","year":"2013","journal-title":"Chem. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00018-018-2954-1","article-title":"Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells","volume":"76","author":"Witucka","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2147\/IJN.S244849","article-title":"Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy","volume":"15","author":"Cao","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2147\/DDDT.S127328","article-title":"Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance","volume":"11","author":"Su","year":"2017","journal-title":"Drug. Des. Devel. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: Mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1038\/sj.onc.1206454","article-title":"Apoptosis and melanoma chemoresistance","volume":"22","author":"Soengas","year":"2003","journal-title":"Oncogene"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, Recognition, and Processing of Cisplatin-DNA Adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chen, S.H., and Chang, J.Y. (2019). New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174136"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: The first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ejmech.2015.08.033","article-title":"Current developments of coumarin-based anti-cancer agents in medicinal chemistry","volume":"102","author":"Emami","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_19","first-page":"3190","article-title":"Anticancer Natural Coumarins as Lead Compounds for the Discovery of New Drugs","volume":"17","author":"Pinto","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.2174\/1381612811319210013","article-title":"Current developments of coumarin compounds in medicinal chemistry","volume":"19","author":"Peng","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2174\/1871520615666150101125503","article-title":"Coumarin: A promising scaffold for anticancer agents","volume":"15","author":"Kaur","year":"2015","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wr\u00f3blewska-\u0141uczka, P., Grabarska, A., Florek-\u0141uszczki, M., Plewa, Z., and \u0141uszczki, J.J. (2021). Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020537"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0306-3623(95)02112-4","article-title":"Pharmacological and biochemical actions of simple coumarins: Natural products with therapeutic potential","volume":"27","author":"Hoult","year":"1996","journal-title":"Gen. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1515\/znc-2007-1-211","article-title":"Scoparone inhibits ultraviolet radiation-induced lipid peroxidation","volume":"62","author":"Sourivong","year":"2007","journal-title":"Z Naturforsch C J. Biosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1248\/bpb.30.242","article-title":"Inhibition of cytokine-mediated nitric oxide synthase expression in rat insulinoma cells by scoparone","volume":"30","author":"Kim","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"105170","DOI":"10.1016\/j.phrs.2020.105170","article-title":"Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action","volume":"160","author":"Hui","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.lfs.2005.11.020","article-title":"Scoparone inhibits PMA-induced IL-8 and MCP-1 production through suppression of NF-kappaB activation in U937 cells","volume":"78","author":"Jang","year":"2006","journal-title":"Life Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/sj.jp.7210643","article-title":"Neonatal jaundice-traditional Chinese medicine approach","volume":"21","author":"Fok","year":"2001","journal-title":"J. Perinatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI200418385","article-title":"A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR","volume":"113","author":"Huang","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2004.02.065","article-title":"Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells","volume":"1009","author":"Andres","year":"2004","journal-title":"Brain Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3892\/mmr.2014.2529","article-title":"Antibacterial mechanism of fraxetin against Staphylococcus aureus","volume":"10","author":"Wang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.intimp.2018.01.027","article-title":"The therapeutic effect of fraxetin on ethanol-induced hepatic fibrosis by enhancing ethanol metabolism, inhibiting oxidative stress and modulating inflammatory mediators in rats","volume":"56","author":"Chen","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1620\/tjem.248.3","article-title":"Fraxetin Suppresses Proliferation of Non-Small-Cell Lung Cancer Cells via Preventing Activation of Signal Transducer and Activator of Transcription 3","volume":"248","author":"Zhang","year":"2019","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.foodchem.2007.02.023","article-title":"Antioxidant properties of Cortex Fraxini and its simple coumarins","volume":"104","author":"Wu","year":"2007","journal-title":"Food Chem."},{"key":"ref_35","first-page":"49","article-title":"Modifications on antioxidant capacity and lipid peroxidation in mice under fraxetin treatment","volume":"49","author":"Villar","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2015.02.001","article-title":"An optimized lactate dehydrogenase release assay for screening of drug candidates in neuroscience","volume":"73","author":"Kaja","year":"2015","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Marz\u0119da, P., Wr\u00f3blewska-\u0141uczka, P., Drozd, M., Florek-\u0141uszczki, M., Za\u0142uska-Ogryzek, K., and \u0141uszczki, J.J. (2022). Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines\u2014An Isobolographic Analysis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126752"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Wr\u00f3blewska-\u0141uczka, P., Cabaj, J., B\u0105k, W., Bargie\u0142, J., Grabarska, A., G\u00f3ralczyk, A., and \u0141uszczki, J.J. (2022). Additive Interactions between Betulinic Acid and Two Taxanes in In Vitro Tests against Four Human Malignant Melanoma Cell Lines. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179641"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Teixido, C., Castillo, P., Martinez-Vila, C., Arance, A., and Alos, L. (2021). Molecular Markers and Targets in Melanoma. Cells, 10.","DOI":"10.3390\/cells10092320"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jid.2020.03.943","article-title":"Treatment of Advanced Melanoma in 2020 and Beyond","volume":"141","author":"Jenkins","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1055\/a-0835-2301","article-title":"Metabolism of Scoparone in Experimental Animals and Humans","volume":"85","author":"Juvonen","year":"2019","journal-title":"Planta Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Kim, J.K., Kim, J.Y., Kim, H.J., Park, K.G., Harris, R.A., Cho, W.J., Lee, J.T., and Lee, I.K. (2013). Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080391"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"(2006). YANG; JY; KOO; JH; SONG; YG; KWON; KB; LEE; JH; SOHN; HS; PARK; BH; JHEE; EC; PARK; JW Stimulation of melanogenesis by scoparone in B16 melanoma cells. Acta Pharmacol. Sin., 27, 1467\u20131473.","DOI":"10.1111\/j.1745-7254.2006.00435.x"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"105777","DOI":"10.1016\/j.biocel.2020.105777","article-title":"Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2\/signal transducer and activator of transcription 3 signalling pathway","volume":"125","author":"Ren","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_45","first-page":"7374","article-title":"Effect of fraxetin on proliferation and apoptosis in breast cancer cells","volume":"14","author":"Liu","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_46","first-page":"1500","article-title":"Fraxetin inhibits the proliferation of RL95-2 cells through regulation of metabolism","volume":"13","author":"Xu","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2014.10.048","article-title":"Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-associated macrophages and\/or G1 arrest in tumor cells","volume":"746","author":"Kimura","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Song, J., Ham, J., Hong, T., Song, G., and Lim, W. (2021). Fraxetin Suppresses Cell Proliferation and Induces Apoptosis through Mitochondria Dysfunction in Human Hepatocellular Carcinoma Cell Lines Huh7 and Hep3B. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13010112"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/1567201812666150702102800","article-title":"A Review on Chemical Profile of Coumarins and their Therapeutic Role in the Treatment of Cancer","volume":"13","author":"Gurupadayya","year":"2016","journal-title":"Curr. Drug. Deliv."},{"key":"ref_50","first-page":"205","article-title":"Combination of Osthole and Cisplatin Against Rhabdomyosarcoma TE671 Cells Yielded Additive Pharmacologic Interaction by Means of Isobolographic Analysis","volume":"38","author":"Guz","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Marrelli, M., Perri, M.R., Amodeo, V., Giordano, F., Statti, G.A., Panno, M.L., and Conforti, F. (2021). Assessment of Photo-Induced Cytotoxic Activity of Cachrys sicula and Cachrys libanotis Enriched-Coumarin Extracts against Human Melanoma Cells. Plants, 10.","DOI":"10.3390\/plants10010123"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/1874467208666161128152518","article-title":"Umbelliferone Decreases Intracellular pH and Sensitizes Melanoma Cell Line A375 to Dacarbazin. Comparison with Acetazolamide","volume":"11","author":"Puech","year":"2018","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_53","first-page":"99","article-title":"A Simplified Method of Evaluating Dose-Effect Experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Grabarska, A., Wr\u00f3blewska-\u0141uczka, P., Kukula-Koch, W., \u0141uszczki, J.J., Kalpoutzakis, E., Adamczuk, G., Skaltsounis, A.L., and Stepulak, A. (2021). Palmatine, a Bioactive Protoberberine Alkaloid Isolated from Berberis cretica, Inhibits the Growth of Human Estrogen Receptor-Positive Breast Cancer Cells and Acts Synergistically and Additively with Doxorubicin. Molecules., 26.","DOI":"10.3390\/molecules26206253"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00210-007-0144-z","article-title":"Isobolographic analysis of interaction between drugs with nonparallel dose-response relationship curves: A practical application","volume":"375","author":"Luszczki","year":"2007","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0024-3205(89)90148-3","article-title":"Statistical analysis of drug-drug and site-site interactions with isobolograms","volume":"45","author":"Tallarida","year":"1989","journal-title":"Life Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1124\/jpet.104.067264","article-title":"Isobolographic analysis for combinations of a full and partial agonist: Curved isoboles","volume":"310","author":"Grabovsky","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-4419-6306-2_17","article-title":"Combination analysis","volume":"678","author":"Tallarida","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Krasowska, D., Gerkowicz, A., Wr\u00f3blewska-\u0141uczka, P., Grabarska, A., Za\u0142uska-Ogryzek, K., Krasowska, D., and \u0141uszczki, J.J. (2022). Anticancer Activity of Amantadine and Evaluation of Its Interactions with Selected Cytostatics in Relation to Human Melanoma Cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147653"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/0471141755.ph0919s72","article-title":"Drug Combinations: Tests and Analysis with Isoboles","volume":"72","author":"Tallarida","year":"2016","journal-title":"Curr. Protoc. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/212\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:48:21Z","timestamp":1760147301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/1\/212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24010212"],"URL":"https:\/\/doi.org\/10.3390\/ijms24010212","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]}}}